Stoke Therapeutics (STOK) EPS (Basic) (2018 - 2026)
Stoke Therapeutics' (STOK) quarterly EPS (Basic) came in at -$0.79 in Q1 2026, down 140.64% year-on-year from $1.95 in Q1 2025, and up 24.8% quarter-over-quarter from -$1.05 in Q4 2025.
Stoke Therapeutics (STOK) EPS (Basic) (2018 - 2026) Analysis & Trends
Stoke Therapeutics' EPS (Basic) history runs 9 years deep, the most recent figure standing at -$0.79 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 140.64% year-over-year to -$0.79 in Q1 2026; TTM through Mar 2026 was -$2.76, a 447.52% decrease from a year earlier, with the FY2025 full-year figure at -$3.45, down 52.81% from the prior year.
- EPS (Basic) improved to -$0.79 in Q1 2026 per STOK's latest filing, from -$1.05 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.95 in Q1 2025 and bottomed at -$3.7 in Q4 2023.
- The 5-year median for EPS (Basic) is -$0.65 (2025), against an average of -$0.82.
- Biggest YoY gain for EPS (Basic) was 442.07% in 2025; the steepest drop was 286.24% in 2025.
- Year by year, EPS (Basic) stood at -$3.2 in 2022, then retreated by 15.55% to -$3.7 in 2023, then surged by 92.62% to -$0.27 in 2024, then slumped by 286.24% to -$1.05 in 2025, then climbed by 24.8% to -$0.79 in 2026.
- Per Business Quant, the three latest STOK EPS (Basic) figures stand at -$0.79 (Q1 2026), -$1.05 (Q4 2025), and -$0.65 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Stoke Therapeutics | 1.87 Bn | 1.53 Bn | - | -0.79 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.79 |
| Dec 31, 2025 | -1.05 |
| Sep 30, 2025 | -0.65 |
| Jun 30, 2025 | -0.40 |
| Mar 31, 2025 | 1.95 |
| Dec 31, 2024 | -0.27 |
| Sep 30, 2024 | -0.47 |
| Jun 30, 2024 | -0.46 |
| Mar 31, 2024 | -0.57 |
| Dec 31, 2023 | -3.70 |
| Sep 30, 2023 | -0.61 |
| Jun 30, 2023 | -0.84 |
| Mar 31, 2023 | -0.58 |
| Dec 31, 2022 | -3.20 |
| Sep 30, 2022 | -0.74 |
| Jun 30, 2022 | -0.82 |
| Mar 31, 2022 | -0.69 |
| Dec 31, 2021 | -2.44 |
| Sep 30, 2021 | -0.69 |
| Jun 30, 2021 | -0.62 |